Lirafit 6 mg/ml Prefilled Pen 3 ml Substitute

Substitutes of Lirafit 6 mg/ml Prefilled Pen 3 ml meet the same safety and efficacy standards as Lirafit 6 mg/ml Prefilled Pen 3 ml, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Lirafit 6 mg/ml Prefilled Pen 3 ml may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Lirafit 6 mg/ml Prefilled Pen 3 ml if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Lirafit 6 mg/ml Prefilled Pen 3 ml for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Lirafit 6 mg/ml Prefilled Pen 3 ml is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Lirafit 6 mg/ml Prefilled Pen 3 ml to its substitute. Always consult your doctor before switching.

Lirafit 6 mg/ml Prefilled Pen 3 ml contains Liraglutide that increases the insulin release from the pancreas after meals when your body has high blood glucose levels. Thus, Lirafit 6 mg/ml Prefilled Pen 3 ml helps in lowering the blood sugar levels in type 2 diabetes mellitus.

Lirafit 6 mg/ml Prefilled Pen 3 ml may cause low blood sugar levels (hypoglycaemia) and can make you hungry, dizzy, irritable, confused, anxious, or shaky. Hence, it is advised to take Lirafit 6 mg/ml Prefilled Pen 3 ml with a meal. To immediately treat hypoglycaemia, it is advised to eat or drink fast-acting sugar sources like fruit juices, hard candy, raisins, or non-diet soda.

Your doctor may advise Lirafit 6 mg/ml Prefilled Pen 3 ml with or without other medications to control your blood sugar levels. However, it is advised to avoid simultaneous use of Lirafit 6 mg/ml Prefilled Pen 3 ml with prandial insulin (mealtime insulin). If you are also using insulin, take Lirafit 6 mg/ml Prefilled Pen 3 ml and insulin injections separately. Please do not mix them. You can inject both injections in the same body region, but the injection sites should not be next to each other.

Lirafit 6 mg/ml Prefilled Pen 3 ml should be used with caution in heart, kidney or liver diseases, pancreatitis (inflammation of the pancreas), stomach disorders like gastroparesis (delayed gastric emptying), high cholesterol levels, gallbladder problems, and depression. Lirafit 6 mg/ml Prefilled Pen 3 ml is contraindicated in patients with multiple endocrine neoplasia type 2 (tumours in thyroid and parathyroid glands) and personal or family history of thyroid cancer.

Take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose.

Store the unused Lirafit 6 mg/ml Prefilled Pen 3 ml pen in a refrigerator at 2°C to 8°C. After its initial use, store Lirafit 6 mg/ml Prefilled Pen 3 ml at room temperature of 15°C to 30°C or in refrigerator and use within 30 days. Do not freeze Lirafit 6 mg/ml Prefilled Pen 3 ml. Do not use Lirafit 6 mg/ml Prefilled Pen 3 ml if it is frozen.